The immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta.

[1]  V. Ling.  Faculty Opinions recommendation of Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. , 2005 .

[2]  G. Zhu,et al.  B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells1 , 2004, The Journal of Immunology.

[3]  C. Dong,et al.  Murine B7-H3 Is a Negative Regulator of T Cells1 , 2004, The Journal of Immunology.

[4]  J. Arroyo,et al.  Deferential regulation of placenta growth factor (PlGF)-mediated signal transduction in human primary term trophoblast and endothelial cells. , 2004, Placenta.

[5]  O. Sandra,et al.  Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? , 2004, Immunology letters.

[6]  J. Kieleczawa,et al.  Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. , 2003, Genomics.

[7]  E. Leung,et al.  Mouse B7-H3 induces antitumor immunity , 2003, Gene Therapy.

[8]  M. Jordana,et al.  The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses , 2003, Nature Immunology.

[9]  J. S. Hunt,et al.  Cell‐specific expression of B lymphocyte (APRIL, BLyS)‐ and Th2 (CD30L/CD153)‐promoting tumor necrosis factor superfamily ligands in human placentas , 2003, Journal of leukocyte biology.

[10]  Lieping Chen,et al.  B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface1 , 2003, Biology of reproduction.

[11]  Lieping Chen,et al.  B7-H1 pathway and its role in the evasion of tumor immunity , 2003, Journal of Molecular Medicine.

[12]  G. Freeman,et al.  Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1 , 2003, The Journal of Immunology.

[13]  A. Rudensky,et al.  Characterization of Mouse and Human B7-H3 Genes1 , 2002, The Journal of Immunology.

[14]  W. Sha,et al.  The right place at the right time: novel B7 family members regulate effector T cell responses. , 2002, Current opinion in immunology.

[15]  Lieping Chen,et al.  B7 family molecules: novel immunomodulators at the maternal-fetal interface. , 2002, Placenta.

[16]  Ping Lu,et al.  B7H Costimulates Clonal Expansion of, and Cognate Destruction of Tumor Cells by, CD8+ T Lymphocytes In Vivo , 2001, The Journal of experimental medicine.

[17]  W. Sha,et al.  Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation1 , 2001, The Journal of Immunology.

[18]  Paul W. Wu,et al.  Differential Expression of Inducible Costimulator-Ligand Splice Variants: Lymphoid Regulation of Mouse GL50-B and Human GL50 Molecules , 2001, The Journal of Immunology.

[19]  D. Pardoll,et al.  B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells , 2001, The Journal of experimental medicine.

[20]  G. Zhu,et al.  B7-H3: A costimulatory molecule for T cell activation and IFN-γ production , 2001, Nature Immunology.

[21]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[22]  H. Frank,et al.  Characterization of trophoblast cell isolations by a modified flow cytometry assay. , 2001, Placenta.

[23]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[24]  G. Freeman,et al.  Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1 , 2000, The Journal of Immunology.

[25]  Paul W. Wu,et al.  Cutting Edge: Identification of GL50, a Novel B7-Like Protein That Functionally Binds to ICOS Receptor , 2000, The Journal of Immunology.

[26]  T. Mak,et al.  T-cell co-stimulation through B7RP-1 and ICOS , 1999, Nature.

[27]  W. Sha,et al.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.

[28]  T. Honjo,et al.  Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. , 1998, International immunology.

[29]  M. Piccinni,et al.  Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions , 1998, Nature Medicine.

[30]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[31]  K. Benirschke,et al.  Pathology of the Human Placenta , 1974, Springer New York.

[32]  H. Ka,et al.  Isolation and culture of term human trophoblast cells. , 2006, Methods in molecular medicine.

[33]  Andreas Radbruch,et al.  Expression of ICOS In Vivo Defines CD4 Effector T Cells with High Inflammatory Potential and a Strong Bias for Secretion of Interleukin 10 , 2003 .

[34]  G. Zhu,et al.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. , 2001, Nature immunology.

[35]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[36]  G. Zhu,et al.  Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. , 2000, Blood.

[37]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[38]  V. Kuchroo,et al.  CD28/B7 costimulation: a review. , 1998, Critical reviews in immunology.

[39]  J. Bluestone,et al.  The B 7 and CD 28 receptor families , 2022 .